Skip to main content

Table 4 Mutations gained in sample 9

From: Chronic COVID-19 infection in an immunosuppressed patient shows changes in lineage over time: a case report

Position

Mutation

Lineage characteristic of

Sample9 (%)

Annotation

Gene

2,832

A → G

BA.1

58.50

K856R (AAG → AGG)

orf1ab → 

6,513

Δ3 bp

Neither

66.00

coding (6248–6250/13203 nt)

orf1ab → 

8,393

G → A

BA.1

78.60

A2710T (GCT → ACT)

orf1ab → 

10,029

C → T

BA.1

57.90

T3255I (ACC → ATC)

orf1ab → 

10,449

C → A

BA.1

63.50

P3395H (CCC → CAC)

orf1ab → 

11,537

A → G

BA.1

54.50

I3758V (ATT → GTT)

orf1ab → 

18,163

A → G

BA.1

51.60

I5967V (ATA → GTA)

orf1ab → 

21,762

C → T

BA.1

58.20

A67V (GCT → GTT)

S → 

21,766

Δ6 bp

BA.1

75.50

coding (204–209/3822 nt)

S → 

21,846

C → T

BA.1

59.90

T95I (ACT → ATT)

S → 

21,987

Δ9 bp

BA.1

65.60

coding (425–433/3822 nt)

S → 

22,194

11 bp → 17 bp

BA.1

58.60

coding (632–642/3822 nt)

S → 

22,578

G → A

BA.1

64.50

G339D (GGT → GAT)

S → 

22,599

G → A

Neither

62.20

R346K (AGA → AAA)

S → 

22,673

T → C

BA.1

58.00

S371P (TCC → CCC) ‡

S → 

22,674

C → T

Neither, but S371L is hallmark of BA.1

62.20

S371F (TCC → TTC) ‡

S → 

22,679

T → C

BA.1

62.20

S373P (TCA → CCA)

S → 

22,686

C → T

BA.1

61.00

S375F (TCC → TTC)

S → 

22,992

G → A

BA.1

88.90

S477N (AGC → AAC)

S → 

22,995

C → A

BA.1

49.10

T478K (ACA → AAA)

S → 

23,040

A → G

BA.1

53.10

Q493R (CAA → CGA)

S → 

23,048

G → A

BA.1

48.10

G496S (GGT → AGT)

S → 

23,055

A → G

BA.1

51.30

Q498R (CAA → CGA)

S → 

23,063

A → T

BA.1

50.70

N501Y (AAT → TAT)

S → 

23,075

T → C

BA.1

51.90

Y505H (TAC → CAC)

S → 

23,202

C → A

BA.1

56.30

T547K (ACA → AAA)

S → 

23,525

C → T

BA.1

100

H655Y (CAT → TAT)

S → 

23,599

T → G

BA.1

49.30

N679K (AAT → AAG)

S → 

23,604

C → A

BA.1

64.20

P681H (CCT → CAT)

S → 

23,854

C → A

BA.1

46.20

N764K (AAC → AAA)

S → 

23,948

G → T

BA.1

44.30

D796Y (GAT → TAT)

S → 

24,130

C → A

BA.1

83.70

N856K (AAC → AAA)

S → 

24,424

A → T

BA.1

61.70

Q954H (CAA → CAT)

S → 

24,469

T → A

BA.1

62.20

N969K (AAT → AAA)

S → 

24,503

C → T

BA.1

62.40

L981F (CTT → TTT)

S → 

26,270

C → T

BA.1

62.80

T9I (ACA → ATA)

E → 

26,530

A → G

BA.1

82.30

D3G (GAT → GGT)

M → 

26,577

C → G

BA.1

54.10

Q19E (CAA → GAA)

M → 

26,709

G → A

BA.1

59.20

A63T (GCT → ACT)

M → 

27,807

C → T

Neither

64.90

intergenic (+ 48/-87)

ORF7a → / → ORF8

28,271

A → T

Neither

67.50

intergenic (+ 12/-3)

ORF8 → / → N

28,311

C → T

BA.1

65.30

P13L (CCC → CTC)

N → 

28,363

Δ9 bp

Neither

65.10

coding (90–98/1260 nt)

N → 

2,832

A → G

BA.1

58.50

K856R (AAG → AGG)

orf1ab → 

  1. Percentages reflect the proportion of sequencing reads with the listed mutation. "Neither" indicates that the mutation is not characteristic of B.1.1.176 or BA.1